A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
ENGLEWOOD, Colo., May 31, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that its Chief Operating Officer, Jarrett Disbrow, and Managing...
Shareholders Authorize Board of Directors to Effect a Reverse Split of the Company's Common StockENGLEWOOD, Colo., May 25, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the...
ENGLEWOOD, Colo., May 24, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that its Chief Executive Officer, Josh Disbrow, will present at The...
ENGLEWOOD, Colo., May 18, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today provided an update on the strategic steps it has taken to expand and optimize...
Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., May 11, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, provided today an overview of...
Confirms Accuracy using Frozen and Thawed Semen Samples, Increasing Potential UseClinical Results Presented at 111th American Urological Association Annual MeetingENGLEWOOD, Colo., May 10, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company...
ENGLEWOOD, Colo., May 6, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on commercializing novel products in the field of urology, today announced the closing of its previously announced underwritten public offering of...
Live Conference Call and Webcast Scheduled for May 11, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., May 5, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...
ENGLEWOOD, Colo., May 2, 2016 -- Aytu BioScience, Inc. ("Aytu") (OTCQX: AYTU), a specialty pharmaceutical company focused on commercializing novel products in the field of urology, today announced that it has priced an underwritten public offering of 18,750,000 shares...
Veteran Financial Executive Carl Dockery Joins AytuENGLEWOOD, Colo., April 13, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, announced today the appointment of Carl Dockery, a...
ENGLEWOOD, Colo., April 5, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, observed encouraging data from two prospective studies of its MiOXSYS™ System that demonstrated...
ENGLEWOOD, Colo., March 31, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on global commercialization of novel products in the field of urology, has obtained Health Canada Class II Medical Device approval for its...
ENGLEWOOD, Colo., March 29, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced that the company has entered into a co-promotion agreement for...
ENGLEWOOD, Colo., March 1, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced that it has entered into a study agreement with Hybridyne Imaging...
Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., Feb. 16, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on developing treatments for urological and related conditions, provided today an overview of its...
Live Conference Call and Webcast Scheduled for February 16, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., Feb. 11, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on developing treatments for urological and related conditions, announced...
ENGLEWOOD, Colo., Feb. 9, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the first commercial sales of its MiOXSYS™ System in Europe...
ENGLEWOOD, Colo., Feb. 3, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, announced today that the Company will present at Source Capital Group's 2016 Disruptive Growth &...
ENGLEWOOD, Co., Jan. 27, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on commercializing treatments for urological and related conditions, today announced that Josh Disbrow, Aytu's Chief Executive Officer, and Jarrett Disbrow,...
Regulatory Clearance Enables Commercialization in Europe and other Key MarketsENGLEWOOD, Colo., Jan. 12, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on commercializing treatments for urological and related conditions, today...
ENGLEWOOD, Colo., Jan. 6, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, announced today that the Company will present at the Biotech Showcase™ 2016, taking place in San...